TTUHSC School of Medicine
Home SOM Cell Biology & Biochemistry

Simon Williams, Ph.D.

Associate Professor
Director of Basic Research,
Southwest Cancer Treatment and Research Center
simon.williams@ttuhsc.edu

Biography

My interests in biology were stimulated in high school by a teacher who introduced me to the concepts of Genetics and that inspired me to study Genetics at Trinity College, Dublin. I then entered a Ph.D. program in Cellular and Molecular Biology at Roswell Park Memorial (now Cancer) Institute in Buffalo, New York and performed my thesis research in the laboratory of Alan Kinniburgh in the Department of Human Genetics. My thesis project focused on the regulation of the mouse apolipoprotein AIV gene in response to dietary lipids and this project was the origin of my interest in transcriptional regulation. I moved to the Frederick Cancer Research and Development Center in Frederick, Maryland for a postdoctoral position in Peter Johnson’s laboratory in 1990. Here, we isolated the various members of the CCAAT/enhancer binding protein family of transcription factors and began to determine their functions. I took one of these proteins, C/EBP? with me to Lubbock, when I started my laboratory in 1995 and the role of C/EBP? in neutrophil differentiation has been the focus of much of our work since then. A newer area of interest for the laboratory emerged from a collaboration with my wife, Kendra Rumbaugh from the Department of Surgery, where we investigate the interactions between host cells and pathogenic bacteria in burn wounds and cystic fibrosis.


Projects

1. Transcriptional regulation of neutrophil differentiation, applications in human leukemias

CCAAT/enhancer binding protein epsilon is a transcriptional regulator that is primarily expressed in, and required for terminal differentiation of neutrophils. Consequently, mutations in the cebpe gene in mice and humans result in immunodeficiency due to defects in innate immunity. In addition, loss of activity of C/EBPε and other members of this family are associated with human leukemias. We are interested in understanding how C/EBPε normally functions to promote neutrophil differentiation and whether therapies that promote C/EBPε activity might be used in treatment of human leukemias. Current areas of focus in this project include the evaluation of the interaction between C/EBPε and the small ubiquitin-like (SUMO) proteins and the interplay between subnuclear localization of C/EBPε and inhibition of its activity in acute promyelocytic leukemia.

Recent Publications

2. Interkingdom signaling: hormonal interactions between pathogenic bacteria and hosts cells in burn wounds and cystic fibrosis.

The Gram negative opportunistic pathogen, Pseudomonas aeruginosa, utilizes an intercellular signaling system named quorum sensing (QS) to coordinate gene expression during infections. The P. aeruginosa QS system utilized lipid based signaling molecules (autoinducers) termed acyl homoserine lactones (AHL), which function as ligands for transcriptional regulators in P. aeruginosa. However, our focus is on the effects of one particular P. aeruginosa AHL, N-3-oxo-dodecanoyl homoserine lactone (3-O-C12-HSL) on mammalian cells in infection scenarios. 3-O-C12-HSL elicits a number of physiological effects on mammalian cells, including the induction of pro-inflammatory gene expression and the induction of apoptosis. We hypothesize that the effects of 3-O-C12-HSL are mediated through mammalian receptor proteins and are currently investigating several candidates. Other projects are looking at the kinetics of autoinducer uptake and the development of chemically-modified autoinducers whose fate can be followed in cells and living organisms. These studies may aid in the development of treatments for P. aeruginosa infections in wounds and the lungs of cystic fibrosis patients.

Recent Publications

3. Abnormal calcium handling in catecholaminergic polymorphic ventricular tacchycardia

Recent Publications

Other Publications